About David Donabedian
David Donabedian is a founding CEO, newleos therapeutics and director at Neela Therapeutics.
Form D filings also name David Donabedian as a director at Anuncia Medical and Alcyone Therapeutics.
David Donabedian first appears on SEC filings in 2012.
Experience
This experience comes from SEC filings. The years are when the filings name David Donabedian in the role, so the role may have started earlier or lasted longer.
Neela Therapeutics, Inc.
Founding CEO, Newleos Therapeutics and director
2025 – 2026 · Lunenburg, MA
Develops precision therapies for children with rare and serious diseases.
Key Colleagues at Startups
The people David Donabedian works with at each company, as listed on that company's latest Form D.
Neela Therapeutics, Inc. · Form D/A, May 26, 2026
RU
Richard Upton
Partner, Harbor Light Capital Partners and director
EJ
Edgar Jannotta Jr.
Board Observer
NR
Norbert Riedel
Chairman of the Board
PA
Pj Anand
Founder, President and Chief Executive Officer, director
SO
Stephen Oesterle
Director
Anuncia Medical, Inc. · Form D/A, Nov 21, 2025
SR
Stanton Rowe
Director
DB
Darryl Baker
Executive officer
EA
Elsa Abruzzo
President and CEO, director
SO
Stephen Oesterle
Director
PA
Pj Anand
Director
GK
Ghassan Kassab
Director
RU
Richard Upton
Director
EJ
Edgar Janotta
Director
Alcyone Therapeutics, Inc. · Form D/A, Jan 8, 2025
EJ
Edgar Jannotta
Director
NR
Norbert Riedel
Director
SO
Stephen Oesterle
Director
PA
Pj Anand
Chief Executive Officer and director
RU
Richard Upton
Director
CD
Cameron Durrant
Director